Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Sylke Inc. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single active matter is assigned to 1 distinct examiner and is located within 1 distinct art unit, reflecting a very narrow and focused prosecution profile. This concentration suggests that the company is currently pursuing a specific biotechnological or pharmaceutical claim rather than a broad array of diverse technologies.
The busiest examiner for the portfolio is SAEED, ALI S, who is responsible for the 1 busiest examiner pending office action currently on record. As the only examiner involved in the company's active filings, their individual review process and technical expertise will be the primary factors determining the outcome. The presence of only 1 distinct examiner means that the applicant's immediate success depends entirely on the interpretation and pace of this single official.
With only 1 pending office action to manage, the company's prosecution overhead is low. The focus on 1 distinct art unit within the Biotechnology & Pharmaceuticals sector allows for a highly targeted legal strategy. However, the lack of diversification across multiple examiners or units means the portfolio is currently sensitive to the specific tendencies of a single point of contact at the patent office. Future filings may expand this reach.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAEED, ALI S | 1 | 31.3% | +35.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18190836 | SCAFFOLD WOUND DRESSING | SAEED, ALI S | 14d |
| Art Unit | Apps |
|---|---|
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18190836 | SCAFFOLD WOUND DRESSING | SAEED, ALI S | 1616 | §103 | Non-Final OA | 14d | Pending | Mar 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial